PortfoliosLab logoPortfoliosLab logo

Sharpe ratio is not yet available for XLVI. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.

How it compares to other similar ETFs

The table compares State Street Health Care Select Sector SPDR Premium Income ETF's Sharpe Ratio with other ETFs in the Derivative Income, Health & Biotech Equities category across multiple time periods, showing how XLVI's risk-adjusted performance compares to similar funds.

Data shows 1-, 5-, and 10-year periods, plus each fund's all-time average, as of Jul 12, 2026.


SymbolName1Y Sharpe Ratio5Y Sharpe Ratio10Y Sharpe RatioAll Time Sharpe Ratio
BBCVirtus LifeSci Biotech Clinical Trials ETF4.23
AMDYYieldMax AMD Option Income Strategy ETF3.62
SBIOALPS Medical Breakthroughs ETF3.48
CHPYYieldMax Semiconductor Portfolio Option Income ETF3.38
GOOYYieldMax GOOGL Option Income Strategy ETF3.25
XBISPDR S&P Biotech ETF3.05
LFSCF/m Emerald Life Sciences Innovation ETF3.05
IHEiShares U.S. Pharmaceuticals ETF2.84
THTASoFi Enhanced Yield ETF2.81
GOOPKurv Yield Premium Strategy Google ETF2.79
XLVIState Street Health Care Select Sector SPDR Premium Income ETF

S&P 500 Index

How to choose period

Historical Sharpe Ratio

The chart shows XLVI's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when XLVI consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.


Loading charts...

Sharpe Ratio Calculator

How does XLVI fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio